Live Nasdaq Composite: Tech Rises on Chip Stock Tailwinds but Software Sinks

Investing

Investing Articles

All Investing Articles

61234 Articles

Chris MacDonald | 1 hour ago

Bitcoin’s Next $1 Trillion Move Could Change Crypto Forever

One trillion dollars. That is the scale of institutional capital that spot crypto ETFs, tokenized securities, and corporate treasuries are…

Vandita Jadeja | 1 hour ago

My Bold Prediction for This Stock Through 2030

Apple (NASDAQ:AAPL | AAPL Price Prediction) just signed a $30 billion multiyear deal with Broadcom for U.S.-made custom silicon and…

Alex Sirois | 1 hour ago

Netflix Vs. Comcast: Buy Netflix For This Reason

Netflix (NASDAQ:NFLX | NFLX Price Prediction) and Comcast (NASDAQ:CMCSA) both reported first quarter results this spring with sharply divergent profiles.…

Joel South | 1 hour ago

Trump Says ‘We Hit Them 20 to 1.’ Wall Street Says That Means a Rate Hike Is Coming in October

President Trump’s boast that “I say we hit them 20 to one. Every time they hit us, we hit them…

Alex Sirois | 1 hour ago

Meta vs Intel: Buy Meta for High-Margin Infrastructure Monetization and Avoid Capital-Strained Intel

Meta (NASDAQ: META | META Price Prediction) and Intel (NASDAQ: INTC) both reported Q1 2026 results that sharpened a debate…

David Moadel | 1 hour ago

Opendoor Jumps 11%, Outpacing Offerpad and Zillow as iBuyer Stock Traders Pick Winners

Shares of Opendoor Technologies (NASDAQ:OPEN) are up 11% to $5.30 at midday Thursday, breaking away from the rest of the…

Chris MacDonald | 1 hour ago

Berkshire Hathaway’s $400 Billion Cash Pile Raises Big Questions

The number in this article’s headline highlights just how massive Berkshire’s real cash hoard has become, and its size raises…

Sam Daodu | 1 hour ago

Is HYPE Better Than XRP? We Compared Price, ETFs, and Growth Potential

A year ago, almost nobody outside of hardcore traders had heard of Hyperliquid. Today, it ranks among the top 10,…

Vandita Jadeja | 1 hour ago

New Price Prediction For this Popular Blue-Chip Dividend Stock

Shares of PepsiCo (NASDAQ:PEP | PEP Price Prediction) slipped after Wednesday’s Q2 filing, opening today near $136.11 after closing at…

Rich Duprey | 2 hours ago

Down 40%, CoreWeave Is Being Left Behind By the Market

The AI infrastructure trade has minted winners across the neocloud sector, but one name has been conspicuously left out. CoreWeave…

Danielle Liverance | 2 hours ago

‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend

Jim Cramer stared down a stock yielding 7% and sitting near its 52-week low, and still would not tell viewers…

Danielle Liverance | 2 hours ago

3 Dividend Stocks You Have to Buy Now to Get Paid in July

The window to lock in three July dividend checks is closing fast. Two of these stocks, Science Applications International and…

John Seetoo | 2 hours ago

GDX vs. GDXJ: Do Senior or Junior Gold Miners Win the Gold Boom?

The choice between the VanEck Gold Miners ETF (NYSEARCA:GDX) and the VanEck Junior Gold Miners ETF (NYSEARCA:GDXJ) looks cosmetic until…

Vandita Jadeja | 2 hours ago

Price Prediction: Will Credo Hit $500 by 2030?

Credo Technology Group (NASDAQ:CRDO | CRDO Price Prediction) is the quiet AI infrastructure story that suddenly is not quiet anymore.…

David Beren | 2 hours ago

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good…

1 2 3 4 … 667

Investing Articles

All Investing Articles

Bitcoin’s Next $1 Trillion Move Could Change Crypto Forever

My Bold Prediction for This Stock Through 2030

Netflix Vs. Comcast: Buy Netflix For This Reason

Trump Says ‘We Hit Them 20 to 1.’ Wall Street Says That Means a Rate Hike Is Coming in October

Meta vs Intel: Buy Meta for High-Margin Infrastructure Monetization and Avoid Capital-Strained Intel

Opendoor Jumps 11%, Outpacing Offerpad and Zillow as iBuyer Stock Traders Pick Winners

Berkshire Hathaway’s $400 Billion Cash Pile Raises Big Questions

Is HYPE Better Than XRP? We Compared Price, ETFs, and Growth Potential

New Price Prediction For this Popular Blue-Chip Dividend Stock

Down 40%, CoreWeave Is Being Left Behind By the Market

‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend

3 Dividend Stocks You Have to Buy Now to Get Paid in July

GDX vs. GDXJ: Do Senior or Junior Gold Miners Win the Gold Boom?

Price Prediction: Will Credo Hit $500 by 2030?

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

Live Nasdaq Composite: Tech Rises on Chip Stock Tailwinds but Software Sinks

Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”

The S&P 500 Is Up 5% This Year. This ‘Cash Cow’ Fund Is Up 9%

Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma

A Retired Couple Faces a Six-Figure Healthcare Bill. Paying It From an HSA, Not an IRA, Keeps It From Taxing Their Social Security.

Why a $1 Million Portfolio Doesn't Guarantee a Comfortable Retirement

Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”

The S&P 500 Is Up 5% This Year. This ‘Cash Cow’ Fund Is Up 9%

Investing Articles

All Investing Articles

Bitcoin’s Next $1 Trillion Move Could Change Crypto Forever

My Bold Prediction for This Stock Through 2030

Netflix Vs. Comcast: Buy Netflix For This Reason

Trump Says ‘We Hit Them 20 to 1.’ Wall Street Says That Means a Rate Hike Is Coming in October

Meta vs Intel: Buy Meta for High-Margin Infrastructure Monetization and Avoid Capital-Strained Intel

Opendoor Jumps 11%, Outpacing Offerpad and Zillow as iBuyer Stock Traders Pick Winners

Berkshire Hathaway’s $400 Billion Cash Pile Raises Big Questions

Is HYPE Better Than XRP? We Compared Price, ETFs, and Growth Potential

New Price Prediction For this Popular Blue-Chip Dividend Stock

Down 40%, CoreWeave Is Being Left Behind By the Market

‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend

3 Dividend Stocks You Have to Buy Now to Get Paid in July

GDX vs. GDXJ: Do Senior or Junior Gold Miners Win the Gold Boom?

Price Prediction: Will Credo Hit $500 by 2030?

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

Live Nasdaq Composite: Tech Rises on Chip Stock Tailwinds but Software Sinks

Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”

The S&P 500 Is Up 5% This Year. This ‘Cash Cow’ Fund Is Up 9%

Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma

Featured Reads

A Retired Couple Faces a Six-Figure Healthcare Bill. Paying It From an HSA, Not an IRA, Keeps It From Taxing Their Social Security.

Why a $1 Million Portfolio Doesn't Guarantee a Comfortable Retirement